Earnings Preview: Aytu BioPharma
Earnings Preview: Aytu BioPharma
Aytu BioPharma (NASDAQ:AYTU) is set to give its latest quarterly earnings report on Wednesday, 2024-02-14. Here's what investors need to know before the announcement.
Analysts estimate that Aytu BioPharma will report an earnings per share (EPS) of $-0.25.
Aytu BioPharma bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Here's a look at Aytu BioPharma's past performance and the resulting price change:
| Quarter | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.95 | -0.63 | -1.60 | |
| EPS Actual | -1.48 | -0.59 | -1.93 | -2.15 |
| Price Change % | -22.11% | 39.06% | -13.21% | -5.78% |
Stock Performance
Shares of Aytu BioPharma were trading at $2.93 as of February 12. Over the last 52-week period, shares are down 2.35%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for Aytu BioPharma visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Aytu BioPharma (NASDAQ:AYTU) is set to give its latest quarterly earnings report on Wednesday, 2024-02-14. Here's what investors need to know before the announcement.
艾圖生物製藥（納斯達克股票代碼：AYTU）定於2024-02-14星期三發佈其最新的季度收益報告。以下是投資者在宣佈之前需要了解的內容。
Analysts estimate that Aytu BioPharma will report an earnings per share (EPS) of $-0.25.
分析師估計，Aytu BioPharma將公佈的每股收益（EPS）爲-0.25美元。
Aytu BioPharma bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
Aytu BioPharma的多頭希望聽到該公司宣佈他們不僅超過了預期，而且爲下一季度提供了積極的指導或預測的增長。
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
新投資者應注意，有時對股票價格影響最大的不是收益超過或失敗，而是指導方針（或預測）。
Here's a look at Aytu BioPharma's past performance and the resulting price change:
以下是Aytu BioPharma過去的表現以及由此產生的價格變化：
| Quarter | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.95 | -0.63 | -1.60 | |
| EPS Actual | -1.48 | -0.59 | -1.93 | -2.15 |
| Price Change % | -22.11% | 39.06% | -13.21% | -5.78% |
| 季度 | 2024 年第一季度 | 2023 年第四季度 | 2023 年第三季度 | 2023 年第二季度 |
|---|---|---|---|---|
| 每股收益估算 | -0.95 | -0.63 | -1.60 | |
| 實際每股收益 | -1.48 | -0.59 | -1.93 | -2.15 |
| 價格變動% | -22.11% | 39.06% | -13.21% | -5.78% |
Stock Performance
股票表現
Shares of Aytu BioPharma were trading at $2.93 as of February 12. Over the last 52-week period, shares are down 2.35%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
截至2月12日，Aytu BioPharma的股票交易價格爲2.93美元。在過去的52週中，股價下跌了2.35％。鑑於這些回報率通常爲負數，長期股東在本業績發佈時可能會看跌。
To track all earnings releases for Aytu BioPharma visit their earnings calendar on our site.
要追蹤Aytu BioPharma發佈的所有業績，請訪問我們網站上的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧